People who got Covid-19 vaccine boosters after the shots were cleared for those with weakened immune systems had mostly mild to moderate reactions, according to the U.S. Centers for Disease Control and Prevention.
Some 22,191 booster recipients registered with a federal monitoring system starting Aug. 12, when the doses were first authorized on an emergency basis by U.S. regulators, through Sept. 19, the CDC said in a report on Tuesday.
Overall, 71% reported pain at the injection site, while 56% reported fatigue and 43% said they experienced a headache after getting a third dose of a messenger RNA vaccine. The ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.